Purchase of Shares by Directors

RNS Number : 0333I

Induction Healthcare Group PLC

12 April 2022

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

Purchase of Shares by Directors

Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide , announces the following Director purchases of, in aggregate, 364,589 ordinary shares in the Company:

Name	Position	Number of Ordinary Shares Purchased	Price per Ordinary Share	Resultant Shareholding	Percentage of Issued Share Capital
James Balmain	Chief Executive Officer	7,300	54.0987p	706,573	0.77%
Guy Mitchell	Chief Financial Officer	9,200	54.0987p	9,200	0.01%
Hugo Stephenson*	Group Executive Director	100,000	54.0987p	2,226,273	2.42%
Leslie-Ann Reed	Non-Executive Director	57,100	52.5p	57,100	0.06%
Andy Williams	Non-Executive Director	190,989	52.5p	610,484	0.66%

* Dr Stephenson's shareholding shown above e xcludes the 7,152,600 ordinary shares which are held by Blue Muse Investments Pty Ltd, as trustee of The Blue Muse Trust (a trust which is controlled by Hugo Stephenson's mother and of which close relatives including his children and friends of Hugo Stephenson are beneficiaries).

ENQUIRIES

Induction James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer	Via Walbrook PR Ltd: [e-mail]
Singer Capital Markets (Nominated Adviser and Broker)	[phone]
Philip Davies / Kailey Aliyar
Walbrook PR Ltd	[e-mail]
Paul McManus / Alice Woodings	Mob: [phone]

About Induction -   www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - enabling a more flexible, efficient and positive experience for the communities they serve . Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.  

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	James Balmain
2.	Reason for the notification
a.	Position/status	Chief Executive Officer
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Induction Healthcare Group plc
b.	LEI	213800RY96GCZQW5TP19
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 0.5 pence each GB00BJ0M3545
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	54.0987 pence 7,300 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	11 April 2022
f.	Place of the transaction	London Stock Exchange
1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Guy Mitchell
2.	Reason for the notification
a.	Position/status	Chief Financial Officer
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Induction Healthcare Group plc
b.	LEI	213800RY96GCZQW5TP19
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 0.5 pence each GB00BJ0M3545
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	54.0987 pence 9,200 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	11 April 2022
f.	Place of the transaction	London Stock Exchange

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Hugo Stephenson
2.	Reason for the notification
a.	Position/status	Group Executive Director
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Induction Healthcare Group plc
b.	LEI	213800RY96GCZQW5TP19
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 0.5 pence each GB00BJ0M3545
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	54.0987 pence 100,000 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	11 April 2022
f.	Place of the transaction	London Stock Exchange

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Leslie-Ann Reed
2.	Reason for the notification
a.	Position/status	Non-Executive Director
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Induction Healthcare Group plc
b.	LEI	213800RY96GCZQW5TP19
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 0.5 pence each GB00BJ0M3545
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	52.5 pence 57,100 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	11 April 2022
f.	Place of the transaction	London Stock Exchange

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Andy Williams
2.	Reason for the notification
a.	Position/status	Non-Executive Director
a.	Initial notification /Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Induction Healthcare Group plc
b.	LEI	213800RY96GCZQW5TP19
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 0.5 pence each GB00BJ0M3545
b.	Nature of the transaction	Purchase of Ordinary Shares
c.	Price(s) and volume(s)	52.5 pence 190,989 Ordinary Shares
d.	Aggregated information ·Aggregated volume ·Price	N/A
e.	Date of the transaction	11 April 2022
f.	Place of the transaction	London Stock Exchange

 

END

 

 

DSHUAAKRUUUSAAR